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Whilst most bacteria involved in dentoalveolar infection are highly susceptible to 2 
penicillin, some Prevotella strains exhibit resistant to this agent through the production 3 
of β-lactamase.  The production of β-lactamase by Prevotella is in turn associated with 4 
the expression of the gene, cfxA/A2.  The aim of the present study was to determine the 5 
prevalence of cfxA/A2 in Prevotella strains using real-time PCR and to assess the 6 
performance of this molecular method for the direct detection of the gene in 87 clinical 7 
samples (pus and root canal exudates) from dentoalveolar infection.  Production of 8 
β-lactamase by each isolate was determined using a nitrocefin disk.  β-lactamase 9 
production was seen in 31% of Prevotella isolates, whilst all isolates of other species 10 
were β-lactamase negative.  The penicillin resistance of isolates strongly correlated 11 
with the production of β-lactamase.  Real-time PCR was found to detect the cfxA/A2 12 
gene from at least five cells per reaction mixture (5×103 cfu/ml of pus).  Using 13 
real-time PCR, cfxA/A2 was evident for all 48 β-lactamase-positive Prevotella strains.  14 
In contrast, neither β-lactamase-negative Prevotella (n=91) or non-Prevotella strains 15 
(n=31) were positive for the gene.  In this study, 31 of the 87 samples yielded 16 
β-lactamase-positive Prevotella, and cfxA/A2 was detected in all 31 samples.  Of the 56 17 
culture-negative samples, 8 (14%) were positive for cfxA/A2 by the real-time PCR.  18 
This sensitive and specific molecular method offers a rapid clinical test for aiding in the 19 
selection of an appropriate antibiotic for treatment of dentoalveolar infection.  20 
Although penicillin remains largely effective in the treatment of dentoalveolar infection, 21 
ß-lactamase stable antibiotics should be considered in cases where ß-lactamase positive 22 
Prevotella are involved. 23 
 3 
INTRODUCTION 1 
Despite the improvement of dental health in developed countries, patients with 2 
dentoalveolar infections are still encountered.  The majority of infections are 3 
associated with necrotic dental pulp tissue, although periodontal diseases and 4 
pericornitis may also provide a source of infection (2).  Drainage, which can be 5 
achieved by tooth extraction, surgical incision or through root canal, is the most 6 
important factor in treatment of dentoalveolar infections (9, 11, 23, 24).  In addition to 7 
drainage, systemic antibiotic can be prescribed to prevent the spread of infection and 8 
onset of serious complications (9, 11, 23, 24).  Members of the penicillin group of 9 
antibiotics have long been the first-line treatment for dental infections because of their 10 
suitable antimicrobial spectrum, bactericidal activity, low incidence of adverse effects 11 
and cost-effectiveness (1, 9, 11, 12, 23, 24). 12 
The antimicrobial susceptibility of bacteria involved in the infection is a 13 
primary factor affecting the likely outcome of antibiotic therapy (9, 10, 24).  The 14 
presence of penicillin-resistant bacteria is implicated as the cause of clinical failure of 15 
treatment in some cases of oral purulent infection (10).  As a consequence, information 16 
determining whether penicillin-resistant bacteria are involved is important in predicting 17 
the effectiveness of treatment with penicillin for dentoalveolar infection.  Although 18 
antibiotic sensitivity can be determined from standard cultural microbiological analysis, 19 
this generally takes several days due to the slow growth of fastidious anaerobic bacteria.  20 
Since infection can spread rapidly and cause severe complications such as sepsis and 21 
obstruction of the airway, such a delay can prove problematic and undesirable. 22 
The introduction of polymerase chain reaction (PCR)-based techniques has 23 
resulted in the development of tests that can detect specific pathogens and genes directly 24 
 4 
and rapidly from clinical samples.  Indeed, conventional PCR has already become an 1 
important tool in clinical diagnostic and research laboratories.  Recently, a more rapid, 2 
sensitive and reproducible PCR has been described and is termed real-time PCR (18).  3 
This approach also allows the quantitative assessment of target nucleic acid. 4 
Dentoalveolar infection usually involves bacteria residing in the oral cavity.  5 
In particular, strict anaerobes such as Peptostreptococcus, Prevotella and 6 
Fusobacterium, and oral streptococci are the predominant isolates from the infection (9, 7 
11-15, 23, 24).  It has been demonstrated that the majority of these bacteria are highly 8 
susceptible to penicillin whilst some Prevotella strains have recently been reported as 9 
being resistant (9, 11-17, 24).  Penicillin-resistance of Prevotella is closely associated 10 
with the production of β-lactamase, which is an enzyme that degrades β-lactam agents 11 
(12-15, 24).  β-lactamase produced by Prevotella has the property of class A/group 2e 12 
β-lactamases, which hydrolyzes most penicillins and broad-spectrum cephalosporins but 13 
are inactive to penicillin combined with clavulanic acid and imipenem (3).  Although 14 
the genetic basis of β-lactamase-production by Prevotella has not been clarified 15 
completely, it has been demonstrated that the cfxA2 gene is associated with β-lactamase 16 
production (3, 6, 19).  This gene shares 98% identity with cfxA, the structural gene of a 17 
β-lactamase produced by Bacteroides vulgatus (19). 18 
The aim of this study was to determine the prevalence of cfxA/A2 in Prevotella 19 
strains using real-time PCR and to assess the performance of this approach for direct 20 
gene detection in clinical samples from dentoalveolar infection. 21 
 22 
MATERIALS AND METHODS 23 
Clinical samples.  A total of 87 clinical samples were obtained from patients with 24 
 5 
dentoalveolar infection (53 males, 34 females; mean age 48.1 years) attending the Oral 1 
and Maxillofacial Surgery Clinic of Kanazawa University Hospital between September 2 
2001 and March 2005.  Each of the samples obtained were recovered from distinct and 3 
individual patients.  Seventy-two pus samples (yellow thin pus, 50; blood-like pus 22) 4 
were taken by aspiration from the abscess using a disposable syringe with an 18-G 5 
needle.  Each sample was stored at -80°C prior to analysis by real-time PCR, with a 6 
portion immediately used for cultural bacterial examination.  The remaining 15 7 
samples were pus-like exudates from the root canal of the tooth involved.  These 8 
samples were obtained using three sterilized paper points (size: #25).  Each sample 9 
held within the paper points was suspended in 100 µl of saline by vortexing vigorously 10 
for 20 s.  A 20-µl volume of the suspension was cultured and the remainder stored at 11 
-80°C prior to DNA extraction. 12 
Bacteriological culture examination.  Samples were inoculated aerobically and 13 
microaerophilically on Brucella HK agar (Kyokuto, Tokyo, Japan) containing 5% (v/v) 14 
sheep blood for 48 h at 37°C.  Culture of strict anaerobes was on Brucella HK agar 15 
with 5% (v/v) sheep blood, which was incubated in an anaerobic atmosphere for up to 16 
seven days at 37°C.  Duplicate plates were prepared containing paromomycin (75 17 
mg/L, Pfizer, Tokyo, Japan) and vancomycin (2.5 mg/L, Shionogi, Osaka, Japan) in 18 
order to selectively isolate strictly anaerobic Gram-negative bacilli.  Isolates were 19 
identified by conventional methods (20).  Bacterial growth was recorded to determine 20 
the approximate number of bacteria in each sample.  After identification, a colony of 21 
each isolate was stored at –80°C. 22 
β-lactamase production and antimicrobial susceptibility.  The nitrocefin disk 23 
(Cefinase®; Becton Dickinson, Cockeysville, MA) was used to determine whether 24 
 6 
strains were positive for β-lactamase production (12-14).  Susceptibility of 242 1 
randomly chosen clinical isolates (Prevotella, 139; Fusobacterium, 33; 2 
Peptostreptococcus, 23; Campylobacter, 13; Porphyromonas, 12; Corynebacterium, 4; 3 
Veillonella, 7; Streptococcus, 5; Bacteroides, 3; Bifidobacterium, 1; Gemella, 1; 4 
Lactobacillus, 1) to penicillin G was determined by a disk diffusion method according 5 
to the National Committee for Clinical Laboratory standards (NCCLS) (22).  In 6 
addition, minimum inhibitory concentrations (MICs) of Prevotella isolates for 7 
amoxicillin (Astellas, Tokyo, Japan) and amoxicillin/clavulanate (GlaxoSmithKline, 8 
Middlesex, UK) were determined by the agar dilution method recommended by the 9 
NCCLS (21).  Bacteroides fragilis ATCC 25285 and Bacteroides thetaiotaomicron 10 
ATCC 29741 were used as quality control strains in each test.  The resistance 11 
breakpoint for amoxicillin and amoxicillin/clavulanate was determined to be 2 and 16 12 
µg/ml, respectively, based on the NCCLS guidelines (21). 13 
Extraction of DNA from bacteria.  Tested strains were subcultured on the 14 
Brucella HK agar containing 5% (v/v) sheep blood for 48 h at 37°C, and resulting 15 
colonies suspended in distilled water (100 µl) at a concentration equivalent to a 16 
MacFarland 1.5 standard.  The suspension was heated to 96°C for 10 min, chilled to 17 
4°C for 5 min, and the cell debris removed by centrifugation.  The supernatant was 18 
used as template for PCR. 19 
Extraction of DNA from clinical samples.  A 50-µl volume of pus was 20 
suspended in 50 µl of distilled water and treated as described above.  For root canal 21 
exudates, the suspension (100 µl) was centrifuged at 12000×g for 10 min and the 22 
supernatant (80 µl) discarded.  The concentrate (20 µl of the remainder) was then used 23 
for DNA extraction.  This concentration procedure was also employed for blood-like 24 
 7 
pus samples. 1 
Real-time PCR.  The primers and the TaqMan probe were designed from cfxA 2 
and cfxA2 gene sequences (GenBank accession nos. U38243 and AF11810, 3 
respectively) using Primer Express software version 2 (Applied Biosystems, Foster, 4 
CA).  The nucleotide sequence of the forward primer was 5 
5’-GCGCAAATCCTCCTTTAACAA-3’ (KAG309), and the reverse primer sequence 6 
was 5’-ACCGCCACACCAATTTCG-3’ (KAG310).  The sequence of the real-time 7 
PCR probe was 5’-TGATAGCATTTCTCAAATTGTCTCAGCTTGTCC-3’ (cfxA Taq 8 
Pr).  The cfxA Taq Pr was 5’ end-labeled with 6-carboxyfluoscein (FAM) as the 9 
reporter dye and 3’ end-labeled with 6-carboxytetramethylrhodamine (TAMRA) as the 10 
quencher.  The primers and probe were selected from a region with 100% nucleotide 11 
identity between cfxA and cfxA2.  Although amino acid substitutions of cfxA/A2 have 12 
been reported (6), the target region for PCR-amplification has not been found to differ 13 
in sequence.  The real-time PCR was performed in a 25-µl final volume containing 14 
12.5 µl of Premix Ex Taq (Perfect Real Time; Takara, Kyoto, Japan), 2 µl of DNA 15 
template, 0.5 µl of 10 µM KAG309 and KAG310 primers and 0.5 µl of 10 µM cfxA Taq 16 
Pr probe at a final concentration of 0.2 µM, 0.5 µl of ROX Reference Dye (×50) and 8.5 17 
µl of distilled water.  All reactions were run on an ABI Prism 7000 sequence detection 18 
system (Applied Biosystems) in triplicate with the following cycling parameters; 95°C 19 
for 10 s, followed by 40 cycles of 95°C for 10 s and 60°C for 31 s. 20 
Analytical specificity and sensitivity (detection limit).  Ten CfxA/A2 21 
β-lactamase-positive and 10 β-lactamase-negative Prevotella strains, which had been 22 
stored in our laboratory, were examined to confirm specificity of real-time PCR.  23 
β-lactamase production by all these strains had previously been confirmed using the 24 
 8 
nitrocefin disk, antimicrobial susceptibility tests and the presence of cfxA/A2 by PCR as 1 
described previously (4) using primers (5’-GCAAGTGCAGTTTAAGATT-3’ and 2 
5’-GCTTTAGTTTGCATTTTCATC-3’).  In addition to these Prevotella strains, 3 
clinical isolates of Porphyromonas gingivalis (n=12), Peptostreptococcus micros (n=20), 4 
Fusobacterium nucleatum (n=36), Campylobacter gracilis (n=7) and Veillonella sp. 5 
(n=6) were also examined.  All these strains were β-lactamase negative. 6 
Quantified dilutions of four β-lactamase-positive Prevotella strains (P. intermedia, 7 
2; P. melaninogenica, 1; P. buccae, 1) were prepared by measuring the number of 8 
colony forming units (cfu).  A randomly selected pus sample was confirmed to be 9 
cfxA/A2-negative and β-lactamase-negative using the real-time PCR, conventional PCR 10 
(4), and culture examination.  A 20-µl of each bacterial dilution was mixed with same 11 
volume of the pus.  Bacterial DNA extraction was done as described above. 12 
Ethics for study.  This study was approved by the Ethics Committee of Kanazawa 13 
University Graduate School of Medical Science. 14 
 15 
RESULTS 16 
Growth of bacteria from samples.  Bacterial growth was found in all clinical 17 
samples.  Half of the thin pus samples, 4 of 22 blood-like pus samples and 14 of 15 18 
pus-like exudates from root canal yielded heavy bacteria growth under anaerobic 19 
conditions.  The remaining samples produced limited bacterial growth. 20 
Bacteriology, β-lactamase production and penicillin disk susceptibility.  The 21 
results of cultural bacteriological examination are presented in Table 1.  Prevotella, 22 
Peptostreptococcus, Fusobacterium and Campylobacter were predominantly isolated 23 
from the infections.  Of the Prevotella isolates, 48 (31%) were found to be positive for 24 
 9 
β-lactamase and furthermore, there were no non-Prevotella β-lactamase-positive 1 
isolates detected.  The penicillin disk susceptibility data was 100% concordant with the 2 
results of β-lactamase production test (data not shown). 3 
Analytical specificity and sensitivity of real-time PCR.  Real-time PCR 4 
confirmed the presence of the cfxA/A2 gene for all 10 β-lactamase-positive and none of 5 
the 10 β-lactamase-negative Prevotella strains.  This gene was not detected by 6 
real-time PCR in any strains of Porphyromonas, Peptostreptococcus, Fusobacterium, 7 
Campylobacter and Veillonella.  Using ‘spiked’ pus, real-time PCR revealed a 8 
detection limit of 5×103 bacterial cfu/ml, corresponding to 5 cfu/reaction mixture, for 9 
three Prevotella strains tested.  In one Prevotella strain, the detection limit was 1 ×103 10 
bacterial cfu/ml of pus. 11 
Prevalence of cfxA/A2 in Prevotella species and the MIC for 12 
amoxicillin/clavulanate.  Although a total of 155 Prevotella isolates were recovered 13 
in this study, 16 strains that were stored by freezing, were not subsequently recovered 14 
by culture for the PCR study.  Therefore, to determine the prevalence of cfxA/A2 in 15 
Prevotella, a total of 139 clinical strains were examined.  In this study, 48 (100%) of 16 
the β-lactamase-positive Prevotella were found to be positive for cfxA/A2 by real-time 17 
PCR (Table 2).  In contrast, all β-lactamase-negative strains were negative for the PCR.  18 
The β-lactamase-positive strains were highly susceptible to amoxicillin/clavulanate 19 
although resistance to amoxicillin was recorded for all of the strains (Table 2).  20 
β-lactamase-negative strains exhibited low MICs to both amoxicillin and 21 
amoxicillin/clavulanate with only one strain identified as having low level resistance to 22 
amoxicillin (MIC, 2 µg/ml). 23 
Direct detection of cfxA/A2 from clinical pus samples by real-time PCR.  24 
 10 
Table 3 presents the agreement between cultural examination and PCR with respect to 1 
detection of β-lactamase-positive bacteria.  Cultural bacteriological examination 2 
revealed that 31 (36%) of 87 clinical samples had β-lactamase-positive strains.  Using 3 
the real-time PCR, cfxA/A2 was detected for all these 31 β-lactamase-positive samples.  4 
Additionally, the real-time PCR also detected the resistance gene in 8 (14%) of the 56 5 
samples deemed negative for β-lactamase by culture.  Of these eight samples, six 6 
yielded β-lactamase-negative Prevotella, and no Prevotella isolates were recovered 7 
from the remaining two samples. 8 
 9 
DISCUSSION 10 
Due to improvement of culture and sampling techniques, recent studies demonstrate 11 
that dentoalveolar infections consist predominantly of strict anaerobes (9, 11-15, 23, 24).  12 
Our bacteriological investigation supports the results of these studies. 13 
The nitrocefin method is capable of detecting ß-lactamases produced by almost all 14 
bacterial species and has been commonly used in clinical laboratories (20).  In this 15 
study, the detection of ß-lactamase was limited to Prevotella (Table 1).  Other studies 16 
have revealed that ß-lactamase-positive strains of facultative anaerobic bacteria such as 17 
staphylococci and non-Prevotella anaerobes are also isolated from dental infections (4, 18 
7, 16).  However, even in these previous studies, the incidence of such bacteria and the 19 
prevalence of ß-lactamase-positive strains in these species was very low.  20 
Consequently, with regard to ß-lactamase production, Prevotella would appear be the 21 
most important pathogen in dentoalveolar infection. 22 
It has been reported that cfxA/A2 occurs in 100% of β-lactamase-positive Prevotella 23 
strains from American and Norwegian patients with periodontal disease (8).  French 24 
 11 
investigators have also demonstrated a 100% prevalence of the resistance gene in 1 
β-lactamase-positive Prevotella (6).  Our results are in good agreement with these 2 
studies and indicative that almost all β-lactamase-positive Prevotella strains are positive 3 
for cfxA/A2.  This would further suggest that detection of cfxA/A2 by the molecular 4 
method is a useful indicator in determining β-lactamase producing Prevotella strains.  5 
In addition, although β-lactamase-positive Prevotella are considered to produce 6 
CfxA/A2 variants with minor nucleotide substitutions (6), the real-time PCR parameters, 7 
including the primers and probe employed in the present study appeared to detect 8 
almost all types of cfxA/A2 with high specificity and sensitivity. 9 
There are various chromosomally-encoding and plasmid-mediated genes associated 10 
with β-lactamase production (8).  However, it has been demonstrated that no 11 
Prevotella strain harbors TEM, SHA, OHA, AmpC and CF β-lactamase genes (8), and 12 
very few strains are positive for cepA/cblA (4).  Together with these reports, our results 13 
of cfxA/A2 prevalence and MICs in Prevotella isolates would support that Prevotella 14 
β-lactamases are class A/group 2e β-lactamases (3) and that CfxA/A2 is the most 15 
important and widely distributed β-lactamase produced by Prevotella.   16 
In this study, PCR-positive results were obtained in 100% of clinical samples that 17 
were positive for β-lactamase by culture (Table 3).  In contrast, 14% of the 18 
culture-negative samples were positive by PCR.  If culture is considered the gold 19 
standard, it can be calculated that the diagnostic sensitivity and specificity of the 20 
real-time PCR is 100% and 86%, respectively.  Thus indicating the high performance 21 
of the real-time PCR for direct detection of β-lactamase-positive Prevotella from 22 
clinical samples.  Nevertheless, the question about the significance of culture-negative 23 
PCR-positive samples and clinical relevance could be raised.  As it is likely that 24 
 12 
real-time PCR is more sensitive for the detection target bacteria compared with cultural 1 
examination, it is perhaps not surprising that the PCR detected the resistance gene from 2 
the samples containing low numbers of β-lactamase-positive Prevotella.  It would also 3 
be possible that the resistance gene would be detected by PCR from 4 
β-lactamase-positive Prevotella exhibiting a highly fastidious growth on the culture 5 
media.  In these circumstances, the improved sensitivity of the real-time PCR would be 6 
clinically advantageous. 7 
In clinical laboratories, routine bacteriological investigation generally includes 8 
semi-quantitation by evaluating bacterial growth on agar.  It has previously reported 9 
that multiple strains of the same species can be isolated from the same individual (5), 10 
and indeed, in this study, some clinical samples yielded β-lactamase-positive and 11 
-negative strains of Prevotella species.  It was therefore difficult to determine whether 12 
the cycle threshold (Ct) value accurately reflected the number of cfxA/A2-positive 13 
bacteria in sample.  However, we confirmed that Ct value was roughly correlated with 14 
the count of colonies in cfxA/A2-positive samples that yielded a single phenotype of 15 
suspected Prevotella colonies (data not shown).  This suggests the applicability of real 16 
time PCR for quantitative detection of β-lactamase-positive Prevotella in the clinical 17 
samples although further study is necessary. 18 
Penicillin, and in particular amoxicillin, has been the first-line antibiotic in the 19 
treatment of acute dentoalveolar infection (1, 9, 11, 23, 24).  However, the incidence of 20 
penicillin resistance has brought into question the appropriateness of penicillin in the 21 
management of dental infections (24).  In this study, only Prevotella exhibited 22 
resistance to penicillin, and the penicillin resistance was completely concordant with 23 
β-lactamase production confirming the penicillin resistance mechanism of Prevotella (9, 24 
 13 
14, 24).  These results support the continuance of penicillin use as the first-line 1 
antibiotic therapy, and the proposal that Prevotella remains a highly significant 2 
pathogen when consideration is made concerning treatment with penicillin (25). 3 
The present study has highlighted the high performance of real-time PCR for the 4 
detection of cfxA/A2 in clinical samples of dentoalveolar infection.  This molecular 5 
method could provide a useful and rapid clinical test for aiding the selection of 6 
antibiotic for therapy.  Some antibiotics such as amoxicillin/clavulanate, cefmetazole, 7 
clindamycin and metronidazole have been demonstrated to be effective for 8 
ß-lactamase-positive Prevotella (12, 14, 16, 17).  These should be considered in 9 
circumstances where involvement of β-lactamase-positive Prevotella is indicated.  10 
Since Prevotella is also implicated in other oral and non-oral infections such as 11 
periodontitis, osteomyelitis, sinusitis and sepsis (4, 7, 23), this molecular diagnostic 12 
method may also prove of value in aiding treatment these infections. 13 
 14 
ACKNOWLEDGEMENTS 15 
We would like to thank Professor E. Yamamoto (Kanazawa University) for his support.  16 
We also wish to acknowledge Miss. Y. Ohta, Miss. T. Jyozen, Miss. M. Mori, Dr. S. 17 
Takai, Dr. H. Araki (Kanazawa University) and all technical staffs of Ishikawa 18 
Prefectural Institute of Public Health and Environmental Science for their kind 19 
cooperation.  This work was supported by a grant from the Japan Society for the 20 
Promotion of Science (Grant-in-aid for young scientists, No. 177914443).21 
 14 
REFERENCES 
1. Chow, A. W. 2005. Infections of the oral cavity, neck, and head. p. 787-802. In G. L. 
Mandell, J. E. Benett, R. Dolin. (ed.), Principles and Practice of Infectious Diseases, 
6th ed, Elsevier Churchill Livingstone, Philadelphia. 
2. Dahlén, G. 2002. Microbiology and treatment of dental abscesses and 
periodontal-endodontic lesions. Periodontol. 2000. 28:206-239. 
3. Edwards, R., R. Beringer, and D. Greenwood. 1996. Characterization of 
β-lactamase of Prevotella species. Anaerobes. 2: 217-221. 
4. Fosse, T., I. Madinier, L. Hannoun, C. Giraud-Morin, C. Hitzig, Y. Charbit, 
and S. Ourang. 2002. High prevalence of cfxA β-lactamase in 
aminopenicillin-resistant Prevotella strains isolated from periodontal pockets. Oral. 
Microbiol. Immunol. 17:85-88. 
5. Fukui K, N. Kato, H. Kato, K. Watanabe, and N. Tatematsu. 1999. Incidence of 
Prevotella intermedia and Prevotella nigrescens carriage among family members 
with subclinical periodontal disease. J. Clin. Microbiol. 37: 3141–3145. 
6. Giraud-Morin, C., I. Madinier, and T. Fosse. 2003. Sequence analysis of 
cfxA2-like β-lactamase in Prevotella species. J. Antimicrob. Chemother. 
51:1293-1296. 
7. Handal, T., I. Olsen, C. B. Walker, and D. A. Caugant. 2004. β-lactamase 
production and antimicrobial susceptibility of subgingival bacteria from refractory 
periodontitis. Oral. Microbiol. Immunol. 19: 303-308. 
8. Handal, T., I. Olsen, C. B. Walker, and D. A. Caugant. 2005. Detection and 
characterization of β-lactamase genes in subgingival bacteria from patients with 
refractory periodontitis. FEMS. Microbiol. Lett. 15: 319-324. 
 15 
9. Heimdahl, A. and C. E. Nord. 1985. Treatment of orofacial infections of 
odontogenic origin. Scand. J. Infect. Dis. Suppl. 46:101-105. 
10. Heimdahl, A., L. von Konow, and C. E. Nord. 1980. Isolation of 
β-lactamase-producing Bacteroides strains associated with clinical failures with 
penicillin treatment of human orofacial infections. Arch. Oral. Biol. 25:689-692. 
11. Kuriyama, T., E. G. Absi, D. W. Williams, and M. A. O. Lewis. 2005. An 
outcome audit of the treatment of acute dentoalveolar infection: impact of penicillin 
resistance. Br. Dent. J. 198: 759-763. 
12. Kuriyama, T., T. Karasawa, K. Nakagawa, S. Nakamura, and E. Yamamoto. 
2002. Antimicrobial susceptibility of major pathogens of orofacial odontogenic 
infections to 11 ß-lactam antibiotics. Oral. Microbiol. Immunol. 17: 285-289. 
13. Kuriyama, T., T. Karasawa, K. Nakagawa, Y. Saiki, E. Yamamoto, and S. 
Nakamura. 2000. Bacteriologic features and antimicrobial susceptibility in isolates 
from orofacial odontogenic infections. Oral. Surg. Oral. Med. Oral. Pathol. Oral. 
Radiol. Endod. 90:600-608. 
14. Kuriyama, T., T. Karasawa, K. Nakagawa, E. Yamamoto, and S. Nakamura. 
2001. Incidence of ß-lactamase production and antimicrobial susceptibility of 
anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic 
infections. Oral. Microbiol. Immunol. 16:10-15. 
15. Kuriyama, T., T. Karasawa, K. Nakagawa, E. Yamamoto, and S. Nakamura. 
2002. Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated 
from pus specimens of orofacial odontogenic infections. Oral. Microbiol. Immunol. 
17:132-135. 
16. Kuriyama, T., K. Nakagawa, T. Karasawa, Y. Saiki, E. Yamamoto, and S. 
 16 
Nakamura. 2000. Past administration of ß-lactam antibiotics and increase in the 
emergence of ß-lactamase-producing bacteria in patients with orofacial odontogenic 
infections. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 89:186-192. 
17. Lewis, M. A. O., T. W. MacFarlane, and D. A. McGowan. 1989. Antibiotic 
susceptibilities of bacteria isolated from acute dentoalveolar abscesses. J. 
Antimicrob. Chemother. 23:69-77. 
18. Mackay, I. M. 2004. Real-time PCR in the microbiology laboratory. Clin. 
Microbiol. Infect. 10:190-212. 
19. Madinier, I., T. Fosse, J. Giudicelli, and R. Labia. 2001. Cloning and 
biochemical characterization of a class A β-lactamase from Prevotella intermedia. 
Antimicrob. Agents. Chemother. 45:2386-2389. 
20. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken. 1999.  
Manual of Clinical Microbiology. 7th ed. American Society for Microbiology, 
Washington, D. C. 
21. National Committee for Clinical Laboratory Standards. 1997. Methods for 
antimicrobial susceptibility testing of anaerobic bacteria - 4th ed. Approved 
standard. NCCLS document M11-A4. National Committee for Clinical Laboratory 
Standards, Wayne. 
22. National Committee for Clinical Laboratory Standards. 2000. Performance 
standards for antimicrobial disk susceptibility tests. Approved standard M2-A7. 
National Committee for Clinical Laboratory Standards. Wayne. 
23. Peterson, L.J. 1998. Principles of management and prevention of odontogenic 
infections. p.392-417. In L. J. Peterson, E. Ellis, J. R. Hupp, M. R. Tucker (ed.), 
Contemporary Oral and Maxillofacial Surgery, Mosby, St. Louis. 
 17 
24. Sandor, G., K., D. E. Low, P. L. Judd, and R. J. Davidson. 1998. Antimicrobial 
treatment options in the management of odontogenic infections. J. Can. Dent. Assoc. 
64:508-514. 
25. Stubbs, S., S. F. Park, P. A. Bishop, and M. A. O. Lewis. 1999. Direct detection 
of Prevotella intermedia and P. nigrescens in suppurative oral infection by 
amplification of 16S rRNA gene. J. Med. Microbiol. 48:1017-1022. 
 
 18 
TABLE 1.  Identification and β-lactamase production by isolates from dentoalveolar infection 
No. of β-lactamase-positive 
Species          strains / No. of total isolates (%) 
Prevotella intermedia/nigrescens     12 / 39 (31) 
Prevotella melaninogenica      9 / 21 (43) 
Prevotella denticola       1 / 9 (11) 
Prevotella loescheii        5 / 23 (22) 
Prevotella oralis         8 / 26 (31) 
Prevotella buccae        8 / 24 (33) 
Prevotella oris         5 / 12 (42) 
Prevotella bivia        0/ 1 
Fusobacterium nucleatum/necrophorum   0 / 66 
Peptostreptococcus micros      0 / 55 
Peptostreptococcus prevotii      0 / 4 
Peptostreptococcus anaerobius     0 / 2 
Porphyromonas gingivalis      0 / 16 
Porphyromonas endodontalis      0 / 3 
Porphyromonas asaccharolytica     0 / 3 
Campylobacter gracilis       0 / 33 
Campylobacter rectus       0 / 10 
Bacteroides capillosus       0 / 7 
Gemella morbillorum       0 / 3 
Propionibacterium acnes      0 / 1 
Streptococcus sp.        0 / 27 
Corynebacterium sp.       0 / 14 
Veillonella sp.         0 / 13 
Staphylococcus sp.        0 / 4 
Lactobacillus sp.        0 / 3 
Eubacterium sp.        0 / 2 
Capnocytophaga sp.       0 / 2 
Neisseria sp.         0 / 2 
Actinomyces sp.        0 / 1 
Bifidobacterium sp.        0 / 1 
Unidentified anaerobic Gram-negative bacilli  0 / 12 
Unidentified aerobic Gram-negative bacilli   0 / 12 
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TABLE 2.  Prevalence of cfxA/A2 and antimicrobial susceptibility in Prevotella strains isolated from dentoalveolar infection 
       No. of  No. of cfxA/A2   Amoxicillin      Amoxicillin/clavulanate   
       tested strain positive strain  MIC50 MIC90 Resistance (%)a  MIC50 MIC90 Resistance (%)a 
β-lactamase-positive isolates  48   48    >64  >64  100     2  4  0 
β-lactamase-negative isolates  91   0    0.06  0.25  1     0.06  0.25  0 
a
 Resistance rate. Breakpoint for amoxicillin and amoxicillin/clavulanate resistances was 2 and 16 µg/ml, respectively. 
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TABLE 3.  cfxA/A2 detection from clinical pus samples by real-time PCR 
      No. of sample    No. of sample (%)   
Culture result    sample   cfxA/A2 positive cfxA/A2 negative 
β-lactamase-positive  31    31 (100)   0 
β-lactamase-negative  56    8 (14)a   48 (86) 
a
 Two of the eight samples did not yield Prevotella isolates by culture. 
